InterCure Ltd. Form 6-K Summary
Business Context and Reporting Period
InterCure Ltd. filed this Form 6-K on April 7, 2022, covering the month of April 2022. The filing submits the company’s annual disclosure materials for the year ended December 31, 2021, including comparative management discussion and analysis for 2021 and 2020.
The company is an Israeli foreign private issuer filing annual reports on Form 20-F. Its principal executive offices are in Herzliya, Israel.
Financial Metrics
The filing incorporates or furnishes consolidated financial statements for the year ended December 31, 2021 and management’s discussion of financial condition and results of operations for 2021 and 2020. The provided filing text does not include the underlying financial figures for revenue, profit or loss, cash flow, margins, debt, liquidity, or other quantitative metrics.
Material Changes Versus the Prior Comparable Period
The filing includes comparative MD&A for the years ended December 31, 2021 and 2020, but the provided text does not state the specific year-over-year changes or their amounts.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
The filing includes an Annual Information Form and a press release dated April 6, 2022. The provided text does not describe management guidance, outlook, material risks, contingencies, or unusual items.
Important Facts to Verify
- Review Exhibit 99.3 for reported revenue, profitability, cash flow, balance-sheet liquidity, debt, and other financial metrics.
- Review Exhibit 99.2 for the explanations of changes between 2021 and 2020 and management’s discussion of financial condition.
- Review Exhibit 99.1 for business, regulatory, market, operational, and other risk factors.
- Review Exhibit 99.4 for the April 6, 2022 press release and any guidance or outlook not included in the cover filing.
- Confirm whether any material events occurred after December 31, 2021 that affect interpretation of the annual results.